Literature DB >> 21978938

Development of the i-BODE: validation of the incremental shuttle walking test within the BODE index.

Johanna E A Williams1, Ruth H Green, Vicki Warrington, Michael C Steiner, Mike D L Morgan, Sally J Singh.   

Abstract

BACKGROUND: The BODE index has been shown to predict mortality in COPD. The index includes the 6 min walking test as the measure of exercise capacity. The incremental shuttle walking test (ISWT) is an alternative measure of exercise capacity which can be used to prescribe exercise and has been found to correlate well with peak VO2. The objective of the study was to evaluate the incorporation of the ISWT within the BODE index (named the i-BODE) to predict mortality in COPD.
METHODS: Data was analysed from 633 patients with COPD attending pulmonary rehabilitation over an 11 year period, and mortality determined a minimum of one year on from initial assessment. An i-BODE score was calculated using ISWT(m) then Cox regression analysis evaluated the capacity of the index to predict risk of death.
RESULTS: BMI, ISWT (m), MRC dyspnoea score, pack years and age were all significantly associated with mortality. Cox regression revealed the i-BODE index was an independent and significant predictor of mortality (hazard ratio 1.27 (CI 1.17-1.35), p < 0.001) and Kaplan Meier survival analysis showed each quartile increase in severity in i-BODE score was significantly associated with increased mortality (p < 0.001 by log rank test).
CONCLUSION: We have found the i-BODE index to be an independent predictor of mortality in COPD, even when other strong predictors such as age and pack years are adjusted for. We conclude that the ISWT can be successfully substituted for the 6MWT as an alternative measure of exercise capacity within the BODE index.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21978938     DOI: 10.1016/j.rmed.2011.09.005

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  12 in total

1.  Assessment of anti-reflux treatment on pulmonary ventilation function and inflammatory cytokines in patients with stable chronic obstructive pulmonary disease combined with gastroesophageal reflux.

Authors:  Hang Liu
Journal:  Exp Ther Med       Date:  2018-04-18       Impact factor: 2.447

Review 2.  Systematic Review of the Association Between Laboratory- and Field-Based Exercise Tests and Lung Function in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Martin Bell; Iain Fotheringham; Yogesh Suresh Punekar; John H Riley; Sarah Cockle; Sally J Singh
Journal:  Chronic Obstr Pulm Dis       Date:  2015-07-08

3.  Development of a modified BODE index as a mortality risk measure among older adults with and without chronic obstructive pulmonary disease.

Authors:  Melissa H Roberts; Douglas W Mapel; Shannon Bruse; Hans Petersen; Toru Nyunoya
Journal:  Am J Epidemiol       Date:  2013-08-08       Impact factor: 4.897

4.  Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study.

Authors:  Hana Müllerová; Amit Shukla; Adam Hawkins; Jennifer Quint
Journal:  BMJ Open       Date:  2014-12-18       Impact factor: 2.692

5.  Large-scale external validation and comparison of prognostic models: an application to chronic obstructive pulmonary disease.

Authors:  Beniamino Guerra; Sarah R Haile; Bernd Lamprecht; Ana S Ramírez; Pablo Martinez-Camblor; Bernhard Kaiser; Inmaculada Alfageme; Pere Almagro; Ciro Casanova; Cristóbal Esteban-González; Juan J Soler-Cataluña; Juan P de-Torres; Marc Miravitlles; Bartolome R Celli; Jose M Marin; Gerben Ter Riet; Patricia Sobradillo; Peter Lange; Judith Garcia-Aymerich; Josep M Antó; Alice M Turner; Meilan K Han; Arnulf Langhammer; Linda Leivseth; Per Bakke; Ane Johannessen; Toru Oga; Borja Cosio; Julio Ancochea-Bermúdez; Andres Echazarreta; Nicolas Roche; Pierre-Régis Burgel; Don D Sin; Joan B Soriano; Milo A Puhan
Journal:  BMC Med       Date:  2018-03-02       Impact factor: 8.775

6.  How to carry out a field walking test in chronic respiratory disease.

Authors:  Anne E Holland; Martijn A Spruit; Sally J Singh
Journal:  Breathe (Sheff)       Date:  2015-06

7.  Prognostic value of C-reactive protein, leukocytes, and vitamin d in severe chronic obstructive pulmonary disease.

Authors:  Mia Moberg; Jørgen Vestbo; Gerd Martinez; Peter Lange; Thomas Ringbaek
Journal:  ScientificWorldJournal       Date:  2014-01-21

8.  Relationship between exercise endurance and static hyperinflation in a post hoc analysis of two clinical trials in patients with COPD.

Authors:  Sally Singh; François Maltais; Lee Tombs; William A Fahy; Mitra Vahdati-Bolouri; Nicholas Locantore; John H Riley
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-01-08

9.  CELEB trial: Comparative Effectiveness of Lung volume reduction surgery for Emphysema and Bronchoscopic lung volume reduction with valve placement: a protocol for a randomised controlled trial.

Authors:  Sara Buttery; Samuel V Kemp; Pallav L Shah; David Waller; Simon Jordan; John T Lee; Winston Banya; Michael C Steiner; Nicholas S Hopkinson
Journal:  BMJ Open       Date:  2018-10-17       Impact factor: 2.692

10.  Lung volume reduction eligibility in patients with COPD completing pulmonary rehabilitation: results from the UK National Asthma and COPD Audit Programme.

Authors:  Sara C Buttery; Adam Lewis; Samuel V Kemp; Winston Banya; Jennifer K Quint; Michael C Steiner; Nicholas S Hopkinson
Journal:  BMJ Open       Date:  2020-11-27       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.